Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Diffuse Intrinsic Pontine Glioma × nimotuzumab × 1 year × Clear all

Sponsor

Conditions

Nasopharyngeal Carcinoma 4 Esophageal Neoplasms 4 Esophageal Squamous Cell Carcinoma 3 Squamous Cell Carcinoma of Head and Neck 2 Pancreatic cancer, adult 2 Head and Neck Neoplasms 2 Urinary Bladder Neoplasms 1 Recurrence 1 Pancreatic Neoplasms 1 Neoplasms 1 Neoplasm Metastasis 1 Carcinoma 1 Adenocarcinoma 1

Interventions

Temozolomide 6 Radiotherapy 4 Cyclophosphamide 3 TIC10 compound 2 Specimen Handling 2 Irinotecan 2 Granulocyte-Macrophage Colony-Stimulating Factor 2 Everolimus 2 Etoposide 2 Diphtheria-Tetanus Vaccine 2 tovorafenib 1 temsirolimus 1 spartalizumab 1 ribociclib 1 pembrolizumab 1 lutetium Lu 177 dotatate 1 lorlatinib 1 larotrectinib 1 gallium maltolate 1 fimepinostat 1 etoposide phosphate 1 dostarlimab 1 dipinacoline glutamate 1 dinutuximab 1 cemiplimab 1 balstilimab 1 antineoplaston AS 2-1 1 antineoplaston A10 1 abemaciclib 1 Vorinostat 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡